| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| May 8, 2025 | May 9, 2025 | Fulcrum Therapeutics, Inc. | Principal Accounting Officer | Sell | 47.5 | -498 | -3.42% | ✗ | $2.5K |
| May 7, 2024 | May 9, 2024 | Fulcrum Therapeutics, Inc. | Principal Accounting Officer | Sell | 47.5 | -236 | -2.00% | ✗ | $1.8K |
| Mar 8, 2024 | Mar 8, 2024 | Fulcrum Therapeutics, Inc. | President | Sell | 22.5 | -4,884 | -29.26% | ✗ | $57.2K |
| May 10, 2023 | May 11, 2023 | Fulcrum Therapeutics, Inc. | Principal Accounting Officer | Sell | 47.5 | -210 | -1.30% | ✗ | $695.1 |